Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-03

Clinical Trial Update: Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD [NA]

View source ↗

Summary

A multicenter clinical study investigating SING-IMT for late-stage age-related macular degeneration, including geographic atrophy, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SING-IMT

Snippet

Sponsor: VisionCare, Inc. | Conditions: Age-Related Macular Degeneration, Geographic Atrophy | NA | Status: RECRUITING